A Elsais, C Lund, E Kerty. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » AdultAtorvastatinAutoantibodies/bloodAutoantibodies/immunologyAutoimmune Diseases of the Nervous System/chemically inducedAutoimmune Diseases of the Nervous System/immunologyAzetidines/therapeutic useBlepharoptosis/chemically inducedBlepharoptosis/diagnosisBlepharoptosis/immunologyDiabetes ComplicationsDiagnostic ErrorsDiplopia/chemically inducedDiplopia/diagnosisDiplopia/immunologyEyelid Diseases/diagnosisEzetimibeHeptanoic Acids/adverse effectsHeptanoic Acids/therapeutic useHumansHypercholesterolemia/complicationsHypercholesterolemia/drug therapyMaleMyasthenia Gravis/chemically inducedMyocardial Infarction/complicationsPain/chemically inducedPain/immunologyPravastatin/adverse effectsPyrroles/adverse effectsPyrroles/therapeutic useReceptors, Cholinergic/immunologyRecurrenceStrabismus/chemically inducedStrabismus/surgery
Substances： See more » AutoantibodiesAzetidinesHeptanoic AcidsPyrrolesReceptors, CholinergicAtorvastatinEzetimibePravastatin
Year: 2008 PMID： 18727677 DOI： 10.1111/j.1468-1331.2008.02234.x
Source DB: PubMed Journal: Eur J Neurol ISSN： 1351-5101 Impact factor: 6.089